Chapter 7: Low-Level Laser Therapy (Photobiomodulation)
Low-Level Laser Therapy (LLLT), now more commonly referred to as Photobiomodulation (PBM), has emerged as one of the most promising non-invasive electrophysical modalities for enhancing wound healing. Unlike surgical lasers, which generate sufficient energy to cut, vaporize, or coagulate tissue, low-level lasers operate at much lower energy levels. Their primary purpose is not to destroy tissue but to stimulate normal biological processes that support healing and tissue regeneration.
Chronic diabetic foot ulcers present a unique therapeutic challenge because persistent hyperglycemia, impaired blood circulation, peripheral neuropathy, chronic inflammation, and reduced cellular activity collectively delay wound healing. Photobiomodulation aims to improve these biological abnormalities by delivering light energy directly to the wound and surrounding tissues, thereby stimulating cellular metabolism and promoting repair.
The systematic review that forms the foundation of this ebook included two randomized controlled trials investigating phototherapy for diabetic foot ulcers. Both studies reported more favorable healing outcomes in the experimental groups than in the control groups, suggesting that phototherapy may have beneficial effects when used as an adjunct to conventional wound care. However, because only two studies were available, the evidence remained insufficient for definitive clinical recommendations.
The scientific principles of photobiomodulation are based on the interaction between light and living cells. When low-intensity laser light enters biological tissue, photons are absorbed by intracellular molecules known as chromophores. One of the most important chromophores is cytochrome c oxidase, an enzyme located within the mitochondria. Mitochondria are often referred to as the “powerhouses” of the cell because they generate adenosine triphosphate (ATP), the primary energy source required for virtually all cellular activities.
Absorption of laser energy by cytochrome c oxidase enhances mitochondrial activity, leading to increased ATP production. Higher ATP levels provide cells with additional energy to perform essential functions such as migration, proliferation, protein synthesis, collagen production, and tissue regeneration. This increase in cellular energy is considered one of the principal mechanisms through which photobiomodulation promotes wound healing.
Photobiomodulation also influences the production of reactive oxygen species (ROS). Although excessive ROS production can damage tissues, low concentrations act as important signaling molecules that regulate gene expression, cellular communication, and tissue repair. Properly administered laser therapy generates controlled levels of ROS that activate beneficial cellular pathways without causing oxidative damage.
Another important mechanism involves nitric oxide. Nitric oxide is a naturally occurring signaling molecule that regulates blood vessel diameter and tissue oxygenation. Low-level laser therapy promotes the release of nitric oxide from intracellular stores, resulting in vasodilation and improved microcirculation. Enhanced blood flow increases oxygen and nutrient delivery to the wound while facilitating removal of metabolic waste products. Improved tissue oxygenation supports fibroblast function, collagen synthesis, and angiogenesis.
Fibroblasts are among the primary target cells of photobiomodulation. These connective tissue cells are responsible for synthesizing collagen, elastin, and extracellular matrix proteins that provide structural support for healing tissues. Increased fibroblast proliferation leads to greater collagen deposition, improved granulation tissue formation, and enhanced wound strength.
The systematic review notes that electrophysical modalities have been shown to enhance fibroblast activity and angiogenesis, both of which are fundamental components of successful wound healing. These biological effects provide a plausible explanation for the observed improvements in healing reported in clinical studies.
Angiogenesis, the formation of new blood vessels, is another critical process stimulated by photobiomodulation. Chronic diabetic wounds often suffer from inadequate vascularization, limiting oxygen delivery and delaying tissue repair. Laser therapy stimulates endothelial cell proliferation and promotes the release of vascular endothelial growth factor (VEGF), encouraging the formation of new capillaries within the wound bed. Improved vascularity accelerates tissue regeneration and supports more efficient wound closure.
Inflammation is carefully regulated during normal wound healing. Acute inflammation is necessary for eliminating bacteria and removing damaged tissue; however, chronic diabetic ulcers frequently remain trapped in a prolonged inflammatory phase. Persistent inflammation contributes to tissue destruction, excessive enzyme activity, and delayed healing.
Photobiomodulation appears to modulate inflammatory responses by reducing the production of pro-inflammatory cytokines while increasing anti-inflammatory mediators. This balanced regulation allows the wound to transition more effectively into the proliferative phase of healing without completely suppressing the immune response required for infection control.
Photobiomodulation also stimulates keratinocyte migration. Keratinocytes are the primary cells responsible for re-epithelialization, the process by which new skin covers the wound surface. Faster keratinocyte migration contributes directly to earlier wound closure and restoration of the skin barrier.
Another important benefit is pain reduction. Although diabetic neuropathy often reduces pain sensation, some patients experience chronic wound discomfort or neuropathic pain. Laser therapy may decrease pain by reducing inflammatory mediators, improving local circulation, and modulating nerve activity. Reduced pain may improve patient mobility, treatment adherence, and overall quality of life.
Several different types of therapeutic lasers are available for clinical use. Common systems include helium-neon (He-Ne) lasers, gallium-aluminum-arsenide (GaAlAs) diode lasers, gallium-arsenide (GaAs) lasers, and indium-gallium-aluminum-phosphide (InGaAlP) lasers. Each device produces light at specific wavelengths that determine tissue penetration depth and biological effects.
Red light, typically ranging from 600 to 700 nanometers, penetrates superficial tissues and is often used for skin wounds. Near-infrared light, usually between 780 and 950 nanometers, penetrates more deeply into soft tissues and may influence structures beneath the skin surface. Selection of wavelength depends on the depth and characteristics of the wound being treated.
Successful photobiomodulation requires careful adjustment of treatment parameters. Clinicians must consider wavelength, power output, energy density, treatment duration, treatment frequency, pulse characteristics, and the distance between the laser device and the tissue. Appropriate dosing is particularly important because insufficient energy may produce little therapeutic effect, whereas excessive energy may reduce biological responsiveness. This phenomenon is often referred to as the biphasic dose-response relationship.
Treatment sessions are generally painless and well tolerated. Most patients experience little or no sensation during laser application, making photobiomodulation a comfortable treatment option suitable for repeated clinical use. Sessions typically last several minutes depending on wound size and treatment protocol.
Patient selection remains essential. Low-level laser therapy is generally considered for chronic diabetic foot ulcers that have failed to respond adequately to conventional wound care. Before initiating treatment, clinicians should ensure that infection is appropriately managed, necrotic tissue has been removed, adequate blood supply exists, and pressure offloading has been implemented. Photobiomodulation should always be integrated into comprehensive wound management rather than used as an isolated intervention.
Although low-level laser therapy has demonstrated an excellent safety profile, certain precautions are necessary. Protective eyewear must be worn by both patients and healthcare providers during treatment to prevent accidental retinal exposure. Laser beams should never be directed toward the eyes. Additional caution is advised when treating patients with known malignancies near the treatment area or individuals with photosensitive conditions.
The systematic review evaluated two randomized controlled trials involving phototherapy for diabetic foot ulcers. Both studies reported superior healing outcomes in the laser-treated groups compared with controls, suggesting that photobiomodulation may enhance wound healing when used alongside standard wound care. Nevertheless, the authors concluded that the limited number of available studies prevented firm conclusions regarding its overall clinical effectiveness.
One of the principal limitations identified in current research is the lack of standardized treatment protocols. Considerable variation exists among published studies regarding laser wavelength, power settings, treatment duration, frequency of application, and outcome measurements. These methodological differences make direct comparison between studies difficult and complicate the development of evidence-based clinical guidelines.
Future research should focus on large, well-designed randomized controlled trials involving standardized treatment parameters and long-term follow-up. Such investigations will help determine the optimal laser characteristics, treatment schedules, and patient selection criteria necessary to maximize therapeutic effectiveness.
Advances in laser technology continue to improve portability, treatment precision, and ease of clinical application. Modern photobiomodulation devices are becoming increasingly compact, user-friendly, and suitable for outpatient wound care clinics. Future innovations may include automated energy delivery systems, wearable phototherapy devices, and smart wound dressings incorporating light-emitting technologies.
Photobiomodulation represents an exciting area of regenerative medicine. Although current evidence suggests potential benefits in promoting diabetic foot ulcer healing, particularly through enhanced cellular metabolism, angiogenesis, fibroblast proliferation, and inflammation control, its greatest value lies in its integration with established wound care practices. As the evidence base continues to expand, low-level laser therapy may become an increasingly important adjunctive treatment for chronic diabetic wounds.
